16 September 2026 · The Pharmacist
Pharmacy leaders seek national independent prescribing baseline
Pharmacy leaders have called for the establishment of a national minimum baseline offer for independent prescribing, warning that a failure to standardise access risks creating inconsistent care for patients across the country. The call follows a dedicated roundtable discussion convened by the National Pharmacy Association (NPA) to examine the current state of pharmacist prescribing and its integration into wider healthcare delivery.
The NPA convened the meeting on the back of research indicating that critical bottlenecks are currently restricting the expansion of independent prescribing services. Industry leaders and roundtable attendees expressed strong support for overcoming these constraints, arguing that clear national standards are necessary to resolve existing hurdles and support the wider adoption of prescribing roles among pharmacists.
Representatives emphasised that without a clear, standardised baseline, the deployment of independent prescribing risks developing unevenly, potentially leading to fragmented service coverage for patients. Addressing the systemic bottlenecks highlighted in the NPA research is viewed by sector stakeholders as a priority for enabling consistent, reliable access to pharmacist-led prescribing initiatives nationwide.
For UK online pharmacies and digital health providers, the introduction of a national baseline may eventually influence how remote clinical workflows and independent prescribing pathways are structured and benchmarked across the sector.